The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Post hoc exploratory analysis of two phase 2 trials of quizartinib monotherapy in patients (pts) with FLT3-ITD–mutated (mu) relapsed/refractory (R/R) AML with or without prior 1st-generation FLT3 tyrosine kinase inhibitors (TKI) treatment.
 
Mark J. Levis
Honoraria - Agios; Daiichi Sankyo; Novartis
Consulting or Advisory Role - Agios; Daiichi Sankyo; Novartis
Research Funding - Astellas Pharma; Novartis
 
Catherine Choy Smith
Research Funding - Astellas Pharma (Inst); Fujifilm (Inst); Plexxikon (Inst)
Patents, Royalties, Other Intellectual Property - University of California- San Francisco (Inst)
 
Koji Ishizuka
Employment - Daiichi Sankyo
 
Ken Kobayashi
Employment - AstraZeneca; Daiichi Sankyo
Stock and Other Ownership Interests - AstraZeneca; Daiichi Sankyo
 
Meena Arunachalam
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Yibin Wang
Employment - Daiichi Sankyo
Stock and Other Ownership Interests - Daiichi Sankyo
 
Deborah Lazzaretto
Employment - Daiichi Sankyo
Consulting or Advisory Role - Daiichi Sankyo
Research Funding - Daiichi Sankyo
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Novartis; Pfizer; Takeda
Research Funding - Ambit BioSciences (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst)